Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-085801
Filing Date
2025-04-18
Accepted
2025-04-18 16:43:37
Documents
21
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A d861470dpre14a.htm   iXBRL PRE 14A 552201
6 GRAPHIC g861470g01g01.jpg GRAPHIC 37778
7 GRAPHIC g861470g59g59.jpg GRAPHIC 233502
8 GRAPHIC g861470g60g60.jpg GRAPHIC 163660
9 GRAPHIC g861470g99k01.jpg GRAPHIC 166302
10 GRAPHIC g861470g99k02.jpg GRAPHIC 159114
  Complete submission text file 0001193125-25-085801.txt   2801567

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aplt-20241231.xsd EX-101.SCH 3726
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aplt-20241231_def.xml EX-101.DEF 2940
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20241231_lab.xml EX-101.LAB 3167
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20241231_pre.xml EX-101.PRE 2953
23 EXTRACTED XBRL INSTANCE DOCUMENT d861470dpre14a_htm.xml XML 44240
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38898 | Film No.: 25850750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)